Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Dec-21 6:31 PM View:  | Cheruvu Pavan Chief Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 08-Dec-21 | Grant | 37,567 | -- | -- | 21% 180.43K to 217.99K | |
| 09-Dec-21 6:31 PM View: | Cheruvu Pavan Chief Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 08-Dec-21 | Payment of Exercise | 14,884 | $1.42 | $21,135.30 | (7%) 217.99K to 203.11K | |
| 09-Dec-21 6:31 PM View: | Nassif David W. Chief Financial Officer | Sio Gene Therapies Inc. (SIOX) | 08-Dec-21 | Grant | 17,534 | -- | -- | 52% 34.0K to 51.54K | |
| 09-Dec-21 6:31 PM View: | Nassif David W. Chief Financial Officer | Sio Gene Therapies Inc. (SIOX) | 08-Dec-21 | Payment of Exercise | 6,294 | $1.42 | $8,937.48 | (12%) 51.54K to 45.24K | |
| 24-Mar-21 7:21 PM View: | Cheruvu Pavan Chief Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 23-Mar-21 | Market Purchase | 100,000 | $2.48 | $248,180.00 | 124% 80.43K to 180.43K | (10%) |
| 22-Mar-21 9:25 PM View: | Nassif David W. Chief Financial Officer | Sio Gene Therapies Inc. (SIOX) | 22-Mar-21 | Grant | 15,060 | -- | -- | 79% 18.94K to 34.0K | |
| 19-Mar-21 4:58 PM View: | Corcoran Gavin Chief R&D Officer | Sio Gene Therapies Inc. (SIOX) | 17-Mar-21 | Grant | 16,001 | -- | -- | 163% 9.79K to 25.79K | |
| 19-Mar-21 4:55 PM View: | Cheruvu Pavan Chief Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 17-Mar-21 | Grant | 22,590 | -- | -- | 39% 57.84K to 80.43K | |
| 25-Nov-20 9:07 PM View: | Pande Atul Director | Sio Gene Therapies Inc. (SIOX) | 24-Nov-20 | Market Purchase | 10,000 | $2.34 | $23,399.00 | 43% 23.37K to 33.37K | 42% |
| 10-Jul-20 6:12 PM View: | Pande Atul Director | Sio Gene Therapies Inc. (SIOX) | 08-Jul-20 | Market Purchase | 10,000 | $2.73 | $27,290.00 | 75% 13.37K to 23.37K | 22% |
| 10-Jul-20 6:11 PM View: | Cheruvu Pavan Principal Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 08-Jul-20 | Market Purchase | 37,500 | $2.74 | $102,638.00 | 184% 20.34K to 57.84K | 21% |
| 15-Jun-20 7:38 PM View: | Corcoran Gavin Chief R&D Officer | Sio Gene Therapies Inc. (SIOX) | 12-Jun-20 | Payment of Exercise | 6,211 | $3.46 | $21,490.10 | (39%) 16.0K to 9.79K | 4% |
| 15-Jun-20 7:38 PM View: | Corcoran Gavin Chief R&D Officer | Sio Gene Therapies Inc. (SIOX) | 12-Jun-20 | Grant | 16,002 | -- | -- | 100% 0 to 16.0K | |
| 15-Jun-20 7:40 PM View: | Nassif David W. Principal Financial Officer | Sio Gene Therapies Inc. (SIOX) | 11-Jun-20 | Grant | 15,060 | -- | -- | 165% 9.15K to 24.21K | |
| 15-Jun-20 7:39 PM View: | Cheruvu Pavan Principal Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 11-Jun-20 | Payment of Exercise | 9,755 | $3.09 | $30,142.90 | (32%) 30.09K to 20.34K | (7%) |
| 15-Jun-20 7:40 PM View: | Nassif David W. Principal Financial Officer | Sio Gene Therapies Inc. (SIOX) | 11-Jun-20 | Payment of Exercise | 5,266 | $3.25 | $17,114.50 | (22%) 24.21K to 18.94K | (2%) |
| 15-Jun-20 7:39 PM View: | Cheruvu Pavan Principal Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 11-Jun-20 | Grant | 22,591 | -- | -- | 301% 7.5K to 30.09K | |
| 18-Mar-20 8:20 PM View: | Pande Atul Director | Sio Gene Therapies Inc. (SIOX) | 16-Mar-20 | Market Purchase | 10,000 | $1.78 | $17,844.00 | 297% 3.37K to 13.37K | 86% |
| 27-Feb-20 7:49 PM View: | Roivant Sciences Ltd. 10% Owner | Sio Gene Therapies Inc. (SIOX) | 24-Feb-20 | Private Purchase | 5,333,330 | $3.75 | $20,000,000.00 | 40% 13.24M to 18.58M | |
| 17-Jun-19 7:05 PM View: | Pande Atul Director | Sio Gene Therapies Inc. (SIOX) | 14-Jun-19 | Market Purchase | 3,370 | $5.22 | $17,595.40 | 100% 0 to 3.37K | (36%) |
| 17-Jun-19 7:09 PM View: | Cheruvu Pavan Chief Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 14-Jun-19 | Market Purchase | 7,500 | $5.21 | $39,075.00 | 100% 0 to 7.5K | (36%) |
| 19-Mar-19 4:18 PM View: | Roivant Sciences Ltd. 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 19-Mar-19 5:03 PM View: | MacHado Clarence Patrick 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 19-Mar-19 5:04 PM View: | Dexxon Holdings Ltd. 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 19-Mar-19 5:15 PM View: | Qvt Associates Gp LLC 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 19-Mar-19 4:49 PM View: | Lo Andrew 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 19-Mar-19 5:03 PM View: | Viking Global Investors Lp 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 19-Mar-19 5:06 PM View: | Viking Global Performance LLC 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 19-Mar-19 4:52 PM View: | Svf Investments (uk) Ltd 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 20-Dec-18 6:03 AM View: | MacHado Clarence Patrick 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 20-Dec-18 7:29 AM View: | Dexxon Holdings Ltd. 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 20-Dec-18 6:15 AM View: | Qvt Associates Gp LLC 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 20-Dec-18 8:57 AM View: | Lo Andrew 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 20-Dec-18 9:37 AM View: | Viking Global Investors Lp 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 20-Dec-18 9:38 AM View: | Viking Global Performance LLC 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 20-Dec-18 7:06 AM View: | Svf Investments (uk) Ltd 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 20-Dec-18 6:02 AM View: | Roivant Sciences Ltd. 10% Owner | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 13-Aug-18 5:26 PM View: | Bickerstaff George Director | Sio Gene Therapies Inc. (SIOX) | 09-Aug-18 | Market Purchase | 25,000 | $2.07 | $51,750.00 | 100% 25.0K to 50.0K | (80%) |
| 07-Jun-18 8:21 AM View: | Viking Global Performance LLC 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 07-Jun-18 8:24 AM View: | Svf Investments (uk) Ltd 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 07-Jun-18 7:31 AM View: | Roivant Sciences Ltd. 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 07-Jun-18 7:32 AM View: | MacHado Clarence Patrick 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 07-Jun-18 8:43 AM View: | Dexxon Holdings Ltd. 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 07-Jun-18 8:38 AM View: | Qvt Associates Gp LLC 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 07-Jun-18 8:46 AM View: | Lo Andrew 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 07-Jun-18 8:20 AM View: | Viking Global Investors Lp 10% Owner | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 01-Mar-18 10:00 PM View: | Bickerstaff George Director | Sio Gene Therapies Inc. (SIOX) | 27-Feb-18 | Market Purchase | 25,000 | $1.50 | $37,425.00 | 100% 0 to 25.0K | (72%) |
| 03-Jan-18 8:39 AM View: | Modig Berndt Director | Sio Gene Therapies Inc. (SIOX) | 29-Dec-17 | Option Exercise | 77,914 | $0.90 | $70,122.60 | 100% 0 to 77.91K | |
| 19-Apr-17 4:06 PM View: | Hung David Principal Executive Officer Director | Sio Gene Therapies Inc. (SIOX) | 17-Apr-17 | Private Purchase | 539,375 | $18.54 | $10,000,000.00 | 100% 0 to 539.38K | |
| 19-Apr-17 4:08 PM View: | Vernon W Anthony Director | Sio Gene Therapies Inc. (SIOX) | 17-Apr-17 | Private Purchase | 53,937 | $18.54 | $999,992.00 | 100% 0 to 53.94K |
